LIMITED STAGE SMALL-CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop lung cancer's return in patients who finished chemo-radiation
Disease control OngoingThis study tests whether the drug tarlatamab can delay cancer growth and extend life in people with limited-stage small cell lung cancer who have completed chemotherapy and radiation. About 404 adults will receive either tarlatamab or a placebo. The goal is to see if tarlatamab h…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 17, 2026 03:16 UTC
-
New hope for lung cancer patients: drug combo shows promise in major trial
Disease control OngoingThis study tests whether adding the drug serplulimab to standard chemotherapy and radiation helps people with limited-stage small cell lung cancer live longer without their cancer growing. About 511 adults with this type of lung cancer will take part. The goal is to see if the ne…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 15, 2026 11:55 UTC